To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.
Oxford Quantum Circuits
7 followers
REVOLUTION Medicines
19 followers
Oxford Nanopore Technologies
19 followers
Owkin
9 followers
Krystal Biotech
8 followers
DBV Technologies
8 followers
Autolus
7 followers
Kymera Therapeutics
7 followers
CliniRx
1 follower
Dyne Therapeutics
6 followers
Beta Bionics
5 followers
Celularity
5 followers